209 related articles for article (PubMed ID: 30683129)
1. Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection.
Coya JM; De Matteis L; Giraud-Gatineau A; Biton A; Serrano-Sevilla I; Danckaert A; Dillies MA; Gicquel B; De la Fuente JM; Tailleux L
J Nanobiotechnology; 2019 Jan; 17(1):15. PubMed ID: 30683129
[TBL] [Abstract][Full Text] [Related]
2. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
Elife; 2020 May; 9():. PubMed ID: 32369020
[TBL] [Abstract][Full Text] [Related]
3. Optimal structural design of mannosylated nanocarriers for macrophage targeting.
Chen P; Zhang X; Jia L; Prud'homme RK; Szekely Z; Sinko PJ
J Control Release; 2014 Nov; 194():341-9. PubMed ID: 25220160
[TBL] [Abstract][Full Text] [Related]
4. Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
Chaubey P; Mishra B; Mudavath SL; Patel RR; Chaurasia S; Sundar S; Suvarna V; Monteiro M
Int J Biol Macromol; 2018 May; 111():109-120. PubMed ID: 29307805
[TBL] [Abstract][Full Text] [Related]
5. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
Chaubey P; Mishra B
Carbohydr Polym; 2014 Jan; 101():1101-8. PubMed ID: 24299880
[TBL] [Abstract][Full Text] [Related]
6. Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis.
Prabhu P; Fernandes T; Chaubey P; Kaur P; Narayanan S; Vk R; Sawarkar SP
Drug Deliv Transl Res; 2021 Aug; 11(4):1509-1519. PubMed ID: 34021478
[TBL] [Abstract][Full Text] [Related]
7. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
[TBL] [Abstract][Full Text] [Related]
8. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
Jiang HL; Kang ML; Quan JS; Kang SG; Akaike T; Yoo HS; Cho CS
Biomaterials; 2008 Apr; 29(12):1931-9. PubMed ID: 18221992
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Curdlan sulphate - Chitosan nanoparticles as a drug carrier to target Mycobacterium smegmatis infected macrophages.
Ravindran R; Mitra K; Arumugam SK; Doble M
Carbohydr Polym; 2021 Apr; 258():117686. PubMed ID: 33593559
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Sarwar HS; Sohail MF; Saljoughian N; Rehman AU; Akhtar S; Nadhman A; Yasinzai M; Gendelman HE; Satoskar AR; Shahnaz G
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):521-531. PubMed ID: 29385910
[TBL] [Abstract][Full Text] [Related]
12. Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline.
Pardeshi CV; Agnihotri VV; Patil KY; Pardeshi SR; Surana SJ
Int J Biol Macromol; 2020 Dec; 165(Pt A):445-459. PubMed ID: 32987078
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
[TBL] [Abstract][Full Text] [Related]
14. Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
Choi SR; Britigan BE; Moran DM; Narayanasamy P
PLoS One; 2017; 12(5):e0177987. PubMed ID: 28542623
[TBL] [Abstract][Full Text] [Related]
15. Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.
D'Addio SM; Baldassano S; Shi L; Cheung L; Adamson DH; Bruzek M; Anthony JE; Laskin DL; Sinko PJ; Prud'homme RK
J Control Release; 2013 May; 168(1):41-9. PubMed ID: 23419950
[TBL] [Abstract][Full Text] [Related]
16. Mannosylated Chitosan Nanoparticles Based Macrophage-Targeting Gene Delivery System Enhanced Cellular Uptake and Improved Transfection Efficiency.
Peng Y; Yao W; Wang B; Zong L
J Nanosci Nanotechnol; 2015 Apr; 15(4):2619-27. PubMed ID: 26353473
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
18. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
20. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
Chu S; Tang C; Yin C
Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
